Clinical trial

Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic…

NCT00183950 · University of Southern California, Other · Terminated

Key facts

NCT number NCT00183950
Title Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy
Official title Phase I/II Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy
Lead sponsor University of Southern California, Other
Status Terminated
Phase Phase 1/Phase 2
Study type Interventional
Conditions Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Intervention type Drug
Interventions Noscapine
Enrollment 12
Start date Mar 1, 2000
Primary completion Dec 1, 2006
Completion Dec 1, 2006
First posted Sep 16, 2005
Last update posted May 22, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies